CBD for Health and Wellness:

CBD Gets High Ratings, But Questions Remain

As part of our research on CBD for Health and Wellness: U.S. Market Analysis and Opportunities, Kline & Company has completed a second large-scale consumer attitudes and usage study on CBD. Adult U.S. consumers aged 21 and over make up the sample of nearly 700 consumers nationwide. Awareness is widespread and many consumers have tried CBD, but there are still numerous unanswered questions when it comes to usage.Continue reading

New FDA Approvals

Switch Activity Heating Up with New OTC Approvals

The U.S. FDA announced approval of three Rx-to-OTC switches on February 14, 2020. One is GlaxoSmithKline’s OTC version of its topical nonsteroidal anti-inflammatory (NSAID) pain reliever, Voltaren Gel (diclofenac sodium topical gel, 1%). This OTC medication will be indicated for temporary relief of joint pain and stiffness due to the most common type of arthritis, osteoarthritis, which increases with age, affects millions of people in the U.S., and can generally be self-diagnosed. Arthritis is the swelling and tenderness of one or more of the joints. Symptoms of arthritis include pain, swelling, stiffness, and difficulty moving a joint. This medication has been sold without a prescription safely for years in Europe and marks the first topical analgesic with anti-inflammatory properties available without a prescription in the United States. It also offers another non-opiate option for those suffering from chronic arthritis pain.   Continue reading

U.S. House Judiciary Committee Votes for MORE, Federally Deschedules Cannabis

The Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act passed in the House Judiciary Committee with a 24 to 10 vote on November 21, 2019. The MORE Act is historic because it:

• Removes or “deschedules” marijuana and cannabis from the federal Controlled Substances Act
• Allows states to enact their own cannabis regulations without federal interference
• Provides review and expungement of past cannabis convictions
• Provides reinvestments to communities adversely affected by the drug war Continue reading

Restless Americans Drive Double-Digit Gains in the Sleep Category

The number of consumers suffering from sleeping disorders continues to grow, and quality sleep is a major issue for many Americans. In fact 75.0% of surveyed consumers indicate they have trouble falling asleep. Many use OTC sleep aids, combination OTC pain relievers and sleep aids, natural and herbal remedies, or sleep devices, such as smart watches and sleep tracking apps which posted 50% sales growth to help them sleep. These market segments however, are growing at very different rates. For example, sales of OTC sleep aids like Unisom, ZzzQuil, and Simply Sleep expanded by 3.4%. In contrast, sales of natural and herbal sleep aids that contain melatonin or valerian rose 18.0%, and sleep devices grew over 50.0%, as per Kline’s Sleep Aids study. Continue reading

Many questions about CBD use for health and wellness – Kline report provides insights on consumers’ perceptions of CBD

There is much hype surrounding consumer-use cannabidiol (CBD) for health and wellness. There are hundreds of companies marketing tons of products; however, there is little consumer education or advertising, along with very nebulous claims, if any, about what the products will do for those who take them. There is even less information on dosage recommendations or clear labeling to help consumers understand how much CBD is actually contained in oral drops, tinctures, gummies, and other popular forms. In short, there’s lot of buzz surrounding this ingredient but little substance.Continue reading

Digestive System

Digestive health remains a strong growth category with increased consumer awareness and knowledge of probiotic benefits

There is growing awareness of the connection between probiotics and immunity. Studies show that bacteria found in probiotics assist in the maturation of immune cells and helps reduce undesirable bacteria in the body. More probiotics with immune-boosting claims are entering the category. Research continues to drive interest in probiotics and improved health. Continue reading

The TBD on CBD: FDA Public Hearing Highlights and Needed Actions

With the uptake of consumer CBD (cannabidiol) products rising at record growth rates, the need to assure consumers of product safety and transparency is of elevated importance.  The purpose of the FDA’s Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds public hearing on May 31, 2019 was to give consumers, academia, manufacturers, health care professionals, and other constituents the forum to share their knowledge and/or point of view on CBD, along with their input and/or recommendations to the FDA. Based on the presentations and comments made by manufacturers, Kline’s top three takeaways are as follows:Continue reading

Sleepless Americans Turn to Tech Devices and Natural Products

Restful sleep remains an elusive goal for many adults and therefore, strong gains for sleep aids, including OTC sleep aids, natural sleep products, pain+sleep combination products, and sleep devices are forecast over the next five years by Kline’s Sleep Aids: U.S. Market Analysis and Opportunities study. Estimates range from 30%-40% of American adults experience symptoms of insomnia and 40 million are affected by chronic long-term sleep disorders.Continue reading

Top 70 OTC Indie Brands to Watch in 2019 and Beyond

OTC indies, companies that are driving significant growth are either early adopters of a particular health trend such as Suja Life or Health-Ade Kombucha or companies that are breathing new life into iconic brands such as Infirst, Focus Consumer Healthcare, and Foundation Consumer Healthcare. These brands, collectively, generated almost $1.8 billion in manufacturer-level sales in 2018, representing more than 13% in year-over-year growth, finds the just-published OTC Indies: U.S. Analysis of Independent OTC Companies study by international market research and management consulting firm Kline.Continue reading